QGEN
Qiagen NV
NYSE: QGEN · HEALTHCARE · DIAGNOSTICS & RESEARCH
$50.33
+0.32% today
Updated 2026-10-28
Market cap
$9.53B
P/E ratio
23.42
P/S ratio
4.54x
EPS (TTM)
$1.97
Dividend yield
0.79%
52W range
$32 – $57
Volume
3.7M
Qiagen NV (QGEN) Financial Forecast & Price Target 2030
Revenue-driven projection model with historical context.
Price target summary
Current price
$50.33
12-Month target
$39.87
2030 Target
—
Intrinsic (DCF)
$40.12
Financial forecast
| Metric | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | $2.3B | $2.1B | $2.0B | $2.0B | $2.1B |
| EPS | — | — | — | — | — |
CAGR applied: — (capped 20%) · P/E: 23.42x (capped 25x) · Margin: 19.50%
Methodology
CAGR-based projection model. Research-backed estimates are being generated — check back soon for analyst consensus and management guidance.